These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38584528)

  • 1. Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis.
    Cai F; Xu H; Song S; Wang G; Zhang Y; Qian J; Xu L
    Curr Protein Pept Sci; 2024; 25(7):577-585. PubMed ID: 38584528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
    Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
    Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE2T knockdown inhibits gastric cancer progression.
    Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
    Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma.
    Li R; Nan X; Li M; Rahhal O
    Oncol Res; 2024; 32(8):1323-1334. PubMed ID: 39055892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.
    Deng Y; Chen X; Chen X; Huang C; Zhang Z; Xu Z; Wang X; Wu J; Li L; Song J; Zhou R
    BMC Cancer; 2024 Sep; 24(1):1158. PubMed ID: 39289660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma.
    Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA
    Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overexpression of ubiquitin-conjugating enzyme 2T induces radiotherapy resistance in hepatocellular carcinoma by enriching regulatory T cells in the tumor microenvironment].
    He X; Xiong S; Zhu Z; Sun J; Cao C; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 44(6):1149-1158. PubMed ID: 38977345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma.
    Xu N; Cui Y; Shi H; Guo G; Sun F; Jian T; Rao H
    Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):20. PubMed ID: 35980647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinoma.
    Miao Y; Chen Q; Liu X; Bu J; Zhang Z; Liu T; Yue Z; Huang L; Sun S; Li H; Yang A; Yang Z; Chen C
    Sci Rep; 2024 Jul; 14(1):16972. PubMed ID: 39043683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
    Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
    Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.